Microarray analysis of the role of regional dura mater in cranial suture fate

Plastic and Reconstructive Surgery

Volumn 122, Issue 2, 2008, Pages 389-399

  Kwan, Matthew D ^a   Wan, Derrick C ^a   Wang, Zhen ^a   Gupta, Deepak M ^a   Slater, Bethany J ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ARTICLE; BONE REMODELING; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DISEASE COURSE; DNA HYBRIDIZATION; DURA MATER; EXTRACELLULAR MATRIX; FRONTAL CORTEX; GENE CONTROL; GENE EXPRESSION; GENOMICS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PERINATAL PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACID PHOSPHATASE; AGE FACTORS; ANIMALS; BONE REMODELING; CRANIAL SUTURES; DURA MATER; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; INSULIN-LIKE GROWTH FACTOR II; ISOENZYMES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MUSCLE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARACRINE COMMUNICATION; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 67749088344     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31817d6244     Document Type: Article

References (40)

1. Marchac, D., and Renier, D. Craniosynostosis. World J. Surg. 13: 358, 1989.
2. Roth, D. A., Bradley, J. P., Levine, J. P., McMullen, H. F., McCarthy, J.G., and Longaker, M.T. Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast. Reconstr. Surg. 97: 693, 1996.
3. Levine, J. P., Bradley, J. P., Roth, D. A., McCarthy, J. G., and Longaker, M. T. Studies in cranial suture biology: Regional dura mater determines overlying suture biology. Plast. Reconstr. Surg. 101: 1441, 1998.
4. Sahar, D. E., Longaker, M. T., and Quarto, N. Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev. Biol. 280: 344, 2005.
5. Warren, S. M., Brunet, L. J., Harland, R. M., Economides, A. N., and Longaker, M. T. The BMP antagonist noggin regulates cranial suture fusion. Nature 422: 625, 2003.
6. Mathy, J. A., Lenton, K., Nacamuli, R. P., et al. Fgf-2 stimulation affects calvarial osteoblast biology: Quantitative analysis of nine genes important for cranial suture biology by real-time reverse transcription polymerase chain reaction. Plast. Reconstr. Surg. 112: 528, 2003.
7. Song, H. M., Fong, K. D., Nacamuli, R. P., et al. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus. Plast. Reconstr. Surg. 113: 1685, 2004.
8. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. In vivo modulation of FGF biological activity alters cranial suture fate. Am. J. Pathol. 158: 441, 2001.
9. Mehrara, B. J., Mackool, R. J., McCarthy, J. G., Gittes, G. K., and Longaker, M. T. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. 102: 1805, 1998.
10. Mehrara, B. J., Spector, J. A., Greenwald, J. A., Ueno, H., and Longaker, M. T. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast. Reconstr. Surg. 110: 506, 2002.
11. Mehrara, B. J., Steinbrech, D. S., Saadeh, P. B., Gittes, G. K., and Longaker, M. T. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann. Plast. Surg. 42: 502, 1999.
12. Nacamuli, R. P., Song, H. M., Fang, T. D., et al. Quantitative transcriptional analysis of fusing and nonfusing cranial suture complexes in mice. Plast. Reconstr. Surg. 114: 1818, 2004.
13. Nacamuli, R. P., Fong, K. D., Lenton, K. A., et al. Expression and possible mechanisms of regulation of BMP3in rat cranial sutures. Plast. Reconstr. Surg. 116: 1353, 2005.
14. Fong, K. D., Song, H. M., Nacamuli, R. P., et al. Apoptosis in a rodent model of cranial suture fusion: In situ imaging and gene expression analysis. Plast. Reconstr. Surg. 113: 2037, 2004.
15. Song, H. M., Sahar, D. E., Fong, K. D., et al. In vitro murine posterior frontal suture fate is age-dependent: Implications for cranial suture biology. Plast. Reconstr. Surg. 113: 1192, 2004.
16. Wan, D. C, Aalami, O. O., Wang, Z., et al. Differential gene expression between juvenile and adult dura mater: A window into what genes play a role in the regeneration of membranous bone. Plast. Reconstr. Surg. 118: 851, 2006.
17. Wang, X., and Seed, B. A PCR primer bank for quantitative gene expression analysis. Nucl. Acids Res. 31: e154, 2003.
18. Fowler, F. D., and Ingraham, F. D. A new method for applying polyethylene film to the skull in the treatment of craniosynostosis. J. Neurosurg. 14: 584, 1957.
19. Ingraham, F. D., Alexander, E., and Matson, D. D. Clinical studies in the treatment of craniosynostosis. Surgery 24: 518, 1948.
20. van der Werf, A. J. Craniosynostosis: A new operative technique. Clin. Neurol. Neurosurg. 80: 70, 1977.
21. Marlin, A. E., Brown, W. E., Jr., Huntington, H. W., and Epstein, F. Effect of the dural application of Zenker's solution on the feline brain. Neurosurgery 6: 45, 1980.
22. Warren, S. M., Greenwald, J. A., Nacamuli, R. P., et al. Regional dura mater differentially regulates osteoblast gene expression. J. Craniofac. Surg. 14: 363, 2003.
23. Van Wyk, J.J., and Smith, E. P. Insulin-like growth factors and skeletal growth: Possibilities for therapeutic interventions. J. Clin. Endocrinol. Metab. 84: 4349, 1999.
24. Bradley, J. P., Han, V. K., Roth, D. A., Levine, J. P., McCarthy, J. G, and Longaker, M. T. Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion. Plast. Reconstr. Surg. 104: 129, 1999.
25. Roth, D. A., Gold, L. I., Han, V. K., et al. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast. Reconstr. Surg. 99: 300, 1997.
26. Roth, D. A., Longaker, M. T., McCarthy, J. G, et al. Studies in cranial suture biology: Part I. Increased immunoreactivity for transforming growth factor-beta (β1, β2, β3) during rat cranial suture fusion. J. Bone Miner. Res. 12: 311, 1997.
27. Mooney, M. P., Losken, H. W., Moursi, A. M., et al. Postoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. J. Craniofac. Surg. 18: 336, 2007.
28. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: Implications for suture fusion and patency. J. Bone Miner. Res. 15: 2413, 2000.
29. Opperman, L. A., Nolen, A. A., and Ogle, R. C. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J. Bone Miner. Res. 12: 301, 1997.
30. Cohen, M. M., Jr. The new bone biology: Pathologic, molecular, and clinical correlates. Am. J. Med. Genet. A 140: 2646, 2006.
31. Liu, B., Yu, H. M., and Hsu, W. Craniosynostosis caused by axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation. Dev. Biol. 301: 298, 2007.
32. Lowik, C. W., and van Bezooijen, R. L. Wnt signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J. Musculoskelet. Neuronal Interact. 6: 357, 2006.
33. Poole, K. E., van Bezooijen, R. L., Loveridge, N., et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. F.A.S.E.B. J. 19: 1842, 2005.
34. van Bezooijen, R. L., ten Dijke, P., Papapoulos, S. E., and Lowik, C. W. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev. 16: 319, 2005.
35. van Bezooijen, R. L., Roelen, B. A., Visser, A., et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199: 805, 2004.
36. Holmen, S. L., Zylstra, C. R., Mukherjee, A., et al. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 280: 21162, 2005.
37. Bluteau, G., Julien, M., Magne, D., et al. VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone 40: 568, 2007.
38. Collins, J. M., Ramamoorthy, K., Da Silveira, A., Patston, P., and Mao, J. J. Expression of matrix metalloproteinase genes in the rat intramembranous bone during postnatal growth and upon mechanical stresses. J. Biomech. 38: 485, 2005.
39. Inoue, K., Mikuni-Takagaki, Y., Oikawa, K., et al. A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J. Biol. Chem. 281: 33814, 2006.
40. Lemonnier, J., Hay, E., Delannoy, P., et al. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J. Bone Miner. Res. 16: 832, 2001.